Kite Pharma Garners $127,500,000 New Financing

  • Feed Type
  • Date
    6/19/2014
  • Company Name
    Kite Pharma
  • Mailing Address
    2225 Colorado Avenue Santa Monica, CA 90404 USA
  • Company Description
    Kite Pharma, Inc. (NASDAQ: KITE) is a privately held development stage biotechnology company engaged in the design and development of pioneering immune-based targeted therapies to treat different cancer indications. Kite has a portfolio of proprietary product candidates designed to stimulate the patient’s own immune system to fight tumor cells.
  • Website
    http://www.kitepharma.com
  • Transaction Type
    IPO
  • Transaction Amount
    $127,500,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

Trending on Xconomy